Although the pimeloyl moiety was long known to be a biotin precursor, the mechanism of assembly of this C7 α,ω-dicarboxylic acid was only recently elucidated. In Escherichia coli, pimelate is made by bypassing the strict specificity of the fatty acid synthetic pathway. BioC methylates the free carboxyl of a malonyl thioester, which replaces the usual acetyl thioester primer. This atypical primer is transformed to pimeloyl-acyl carrier protein (ACP) methyl ester by two cycles of fatty acid synthesis. The question is, what stops this product from undergoing further elongation? Although BioH readily cleaves this product in vitro, the enzyme is nonspecific, which made assignment of its physiological substrate problematical, especially because another enzyme, BioF, could also perform this gatekeeping function. We report the 2.05-Å resolution cocrystal structure of a complex of BioH with pimeloyl-ACP methyl ester and use the structure to demonstrate that BioH is the gatekeeper and its physiological substrate is pimeloyl-ACP methyl ester.
Although the pimeloyl moiety was long known to be a biotin precursor, the mechanism of assembly of this C7 α,ω-dicarboxylic acid was only recently elucidated. In Escherichia coli, pimelate is made by bypassing the strict specificity of the fatty acid synthetic pathway. BioC methylates the free carboxyl of a malonyl thioester, which replaces the usual acetyl thioester primer. This atypical primer is transformed to pimeloyl-acyl carrier protein (ACP) methyl ester by two cycles of fatty acid synthesis. The question is, what stops this product from undergoing further elongation? Although BioH readily cleaves this product in vitro, the enzyme is nonspecific, which made assignment of its physiological substrate problematical, especially because another enzyme, BioF, could also perform this gatekeeping function. We report the 2.05-Å resolution cocrystal structure of a complex of BioH with pimeloyl-ACP methyl ester and use the structure to demonstrate that BioH is the gatekeeper and its physiological substrate is pimeloyl-ACP methyl ester.
cofactor biosynthesis | esterase | protein-protein interaction R ecent work delineated the assembly pathway of the enigmatic pimeloyl moiety of biotin. Labeling studies in Escherichia coli had shown that pimelate, a C7 α,ω-dicarboxylic acid, is made by head-to-tail incorporation of three intact acetate units with one of the carboxyl groups being derived from CO 2 (1, 2) . The differing origins of the carboxyl groups indicated that free pimelate was not a synthetic intermediate. The acetate incorporation pattern was consistent with use of the synthetic pathway that produces the usual monocarboxylic fatty acids. However, synthesis of a dicarboxylic acid using the fatty acid synthetic pathway appeared precluded by the strongly hydrophobic active sites of the fatty acid synthetic enzymes (3) , which seemed unlikely to tolerate the charged carboxyl group in place of the usual terminal methyl group. The solution to this conundrum was provided by the characterization of two enzymes, BioC and BioH, which do not directly catalyze pimelate synthesis but instead allow fatty acid synthesis to assemble the pimelate moiety (4) . Such circumvention of the specificity of normal fatty acid synthesis begins by BioC (an Omethyltransferase) conversion of the ω-carboxyl group of malonylacyl carrier protein (ACP) to a methyl ester using S-adenosyl-Lmethionine (SAM) as a methyl donor (Fig. 1 ). Conversion to a methyl ester neutralizes the negative charge and provides a methyl carbon that mimics the methyl ends of normal fatty acyl chains. The malonyl-ACP methyl ester can now enter the fatty acid synthetic pathway where it is condensed with malonyl-ACP by a 3-oxoacyl-ACP synthase in a decarboxylating Claisen reaction to give 3-oxoglutaryl-ACP methyl ester. The methyl ester shielding allows the 3-oxo group to be processed to a methylene group by the standard fatty acid reductase-dehydratase-reductase reaction sequence. The resulting glutaryl-ACP methyl ester would then be elongated to the C7 species, and another round of the reductasedehydratase-reductase cycle would give pimeloyl-ACP methyl ester (Me-pimeloyl-ACP). Once synthesis of the pimelate chain is complete, the ester is no longer required and must be removed, because the freed carboxyl group will eventually be used to attach biotin to essential metabolic enzymes.
Prior experiments demonstrated that BioH is responsible for cleavage of the methyl ester, but the physiological substrate of the enzyme was unclear. Chemical logic argues that the most attractive substrate would be Me-pimeloyl-ACP because its cleavage would act as a gatekeeper to prevent further chain elongation to azelayl-ACP methyl ester, a physiologically useless product. However, because the methyl ester introduced by BioC is at the far end of the pimeloyl moiety from the carbon atom incorporated to initiate the biotin ureido ring, the ester could remain until later in the pathway. In such a case, the gatekeeper function could be provided by BioF, the 7-keto-8-aminopelargonic acid (KAPA) synthase that begins ring formation, because the reaction consumes the thioester required for further fatty acid chain elongation. Hence, the problem distills down to the question of whether BioH acts before or after BioF (Fig. S1A ). This issue is further complicated by the findings that BioH is known to be a rather promiscuous hydrolase. This substrate promiscuity may reflect recent recruitment of E. coli BioH for biotin synthesis and the fact that the bioH gene has not been fully integrated into the biotin synthetic pathway. E. coli bioH differs from the other genes of the pathway in that it is neither located within the bio operon nor regulated by the BirA repressor/ biotin protein ligase (5, 6) , which is in contrast to other bacteria where bioH resides within the biotin operon (7). Thus, the E. coli bioH gene may encode a less-specific protein than those encoded by the integrated bioH genes.
In this paper we report experiments indicating that BioH acts before BioF. However, the promiscuity of both enzymes made this experiment less than compelling, and thus we obtained the 2.05-Å resolution cocrystal structure of a complex of BioH with Mepimeloyl-ACP as an independent test of our interpretation (Fig. 2) . The BioH-ACP interface contacts identified in the structure (Fig.  3 ) were demonstrated to be required for biotin synthesis in vivo, indicating that Me-pimeloyl-ACP is the physiological substrate of BioH, and that BioH is the gatekeeper.
Results
Evidence That BioH Acts Before BioF. The order of action of the genes in a microbial metabolic pathway can often be deduced by Author contributions: V.A., S.L., S.K.N., and J.E.C. designed research; V.A. and S.L. performed research; V.A., S.L., and J.E.C. contributed new reagents/analytic tools; V.A., S.L., T.L., S.K.N., and J.E.C. analyzed data; and V.A., S.L., S.K.N., and J.E.C. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission. C.K. is a guest editor invited by the Editorial Board. cross-feeding experiments among mutant strains. However, in pimelate synthesis this approach fails because the protein-bound intermediates cannot diffuse. To counter this problem, the previously reported in vitro cell-free extract system (4) that converted malonyl-CoA to dethiobiotin (DTB) was simplified to a coupled system where four enzymes convert Me-pimeloyl-ACP to DTB. The design was to add either BioH or BioF to an in vitro system containing the substrates required for their reactions, and then remove the enzyme by use of an affinity tag (Fig. S1A) . The second enzyme (either BioF or BioH) is then added with BioA and BioD and their substrates. Following further incubation, DTB synthesis is assayed. The experiment with addition of BioH or BioF in the opposite order would be done in parallel and the results of the two orders of addition compared. Assuming strict enzyme specificity addition of the enzymes in the correct order would give DTB, whereas the incorrect order of addition would not. However, we expected less than "black or white" results due to the known substrate promiscuity of BioH (8) (9) (10) . The results of these experiments indicated that addition of BioH before BioF gave about twice as much DTB synthesis as the reverse order of addition in all four independent trials of the experiments, one of which is shown in Fig. S1B . Reaction 7 established that BioH cleaves the ω-methyl ester of KAPA methyl ester and that BioF accepts Me-pimeloyl-ACP in place of pimeloyl-ACP, although both off-target reactions are slower than the physiological reactions (reaction 8). Given these off-target reactions, the results we obtained were perhaps as good as might be expected. Another possible source of background would be inefficient removal of the first enzyme. To deal with this possibility, we (rather perversely) used the tag system having the highest known affinity, biotin-streptavidin. The BioH and BioC proteins were expressed as fusions to an affinity tag that becomes biotinylated by the E. coli biotin-protein ligase, BirA. The biotinylated proteins were purified on a monomeric avidin column before use. Control experiments showed that neither protein preparation contained free biotin (which would have scored as DTB; Fig. S1B ). Note that the bead-conjugated streptavidin was added in large molar excess.
Given that the order-of-addition experiments gave the lessthan-ideal results, we sought an independent means to test whether BioH is the gatekeeper. The promiscuity of E. coli BioH raised the question of how a nonspecific enzyme can catalyze a specific reaction. In the absence of other factors, BioH might derail biotin synthesis by hydrolyzing intermediates before Me-pimeloyl-ACP, and thereby abort the pathway. Previously we proposed that the structure of the ACP moiety of the substrate could bestow the needed specificity (4) . Early work on acyl-ACPs demonstrated that the protein sequesters the first 6-8 carbon atoms of the acyl chain from solvent (11), a picture borne out by X-ray structures and molecular dynamics simulations (12) (13) (14) . The protected acyl chain carbon atoms reside within a hydrophobic tunnel formed by a bundle of four helices. Hence, the bundle would largely or completely protect the ester groups of the shorter intermediates from BioH. Only upon chain elongation to the C7 species would the ester group become fully exposed to BioH such that it could enter the active site. In this scenario, the slow hydrolysis of glutaryl-ACP methyl ester would be due to the dynamic nature of ACP structure that would leave the methyl ester transiently unprotected. To test this model of the putative gatekeeper reaction, we solved the cocrystal structure of a complex of Me-pimeloyl-ACP with BioH S82A, which lacks the catalytic serine nucleophile. The binary complex (both proteins were those of E. coli K-12) was crystallized and X-ray diffraction data collected to a limiting resolution of 2.05 Å (relevant data collection and refinement statistics are presented in Table S1 ). The crystals occupy space group P1. Despite attempts using numerous strategies, the data could not be scaled in higher symmetry settings. The crystallographic asymmetric unit consists of two monomers of BioH and two ACP molecules. The arrangement within the asymmetric unit consists of two productive complexes between the BioH holo enzyme and the ACP substrate (Fig. S2) . The average thermal (B) factors are 40.8 Å 2 for the BioH chains and 65.9 Å 2 for the ACP chains, suggesting some degree of flexibility for the ACPs.
BioH belongs to the α/β hydrolase superfamily of enzymes. The tertiary structure consists of a core domain of a seven-member central β-sheet flanked on either side by α helices and a fourhelical capping domain (K121 through T185) present at the top of the loops emanating from the central β-sheet. The canonical S82-H235-D207 catalytic triad of BioH residues lies at the interface of Fig. 1 . Proposed E. coli biotin synthetic pathway showing the catalytic role of BioH. Biotin biosynthesis is initiated by BioC methylation of ACP (or malonyl-CoA) to give malonyl-ACP methyl ester, which, after two successive cycles of fatty acid synthesis (FAS), becomes pimeloyl-ACP methyl ester. Once pimelate is synthesized, BioH hydrolyzes the methyl ester bond to expose the ω-carboxyl group and terminate chain elongation. The ACP moiety is subsequently released in the BioF reaction, the first step of biotin ring assembly. the core and capping domains (9) (Fig. 2) . The S82 to alanine mutation places the Cβ atom of A82 side chain at a distance of 3.1 Å from the pimeloyl carboxylate carbon atom, which would be the site of nucleophilic addition (Fig. S3) . The ACP molecule adopts the well-described four-helix bundle structure with a hydrophobic core described in prior studies of ACP (8) (9) (10) . The second helix of the ACP helical bundle (ACP-α2) lies directly above the BioH capping-domain helices and provides most of the residues that interact with BioH. The ACP serine residue that anchors the phosphopantetheine arm, S35, is positioned at the amino terminus of the ACP-α2 helix.
Ionic Contacts Rigidly Position ACP-α2 Relative to BioH. The contacts between BioH and the ACP molecule are mediated solely by the ACP-α2 helix and the second and third α helices of the BioH capping domain (Fig. S4) . The ACP-α2 is nearly perpendicular to the BioH capping-domain helices, which in turn are antiparallel to each other. Two sites of ionic interactions are predicated on the density of negative charge on the ACP surface, which are engaged by corresponding interactions with basic amino acid side chains in BioH. The first site of interaction occurs between R138 and R142 in BioH and the main chain carbonyl of Q13 and the side chain carboxylates of D34 and D37 in ACP (Fig. 3A) . Slight variability is observed in the interactions of R138 within different BioH-ACP surfaces. The second ionic interaction site engages the guanidinium side chains of R155 and R159 of BioH with the carboxylate side chains of E46 and D55, together with the main chain of I53 in ACP (Fig. 3B ). These two sites lie at either end of the ACP-α2 helix, and are thus postulated to rigidly hold the ACP-α2 in the required position relative to BioH to direct the ACP-S35-conjugated phosphopantetheinylated substrate into the enzyme active site. Additional hydrophobic interactions occur with the side chains of ACP-α2 residues L36, V39, and M43, which project into a completely solvent-occluded cavity generated by BioH residues A145, L146, and M149.
Hydrophobic Interactions Direct the Substrate for Catalysis. Clear and continuous electron density in the difference Fourier maps allows for unambiguous assignment of all atoms of the phosphopantetheine-linked pimeloyl methyl ester (Fig. 2B) , which is covalently attached to Ser35 located in the amino terminus of the ACP-α2 helix. The dipole moment generated by the 14-residue ACP-α2 helix is postulated to stabilize the negative charge of the phosphate group. The phosphopantetheine arm makes minimal contacts with BioH. A water molecule, found only in one of the two complexes, interacts with an amide carbonyl oxygen of the pantetheine arm through a long hydrogen bond (3.4 Å), and is also bonded (3.3 Å) to the K121 main chain amide nitrogen. No other appropriately positioned water molecules can be identified at the interaction site. The phosphopantetheine arm is juxtaposed against a BioH surface lined with hydrophobic amino acid side chains I120, V124, F128, L146, M149, and ACP-L36 ( Fig. 4 and Fig. S5A ).
The five pimeloyl carbon chain methylenes are similarly buttressed by several hydrophobic residues of BioH. These residues construct a very narrow hydrophobic channel that acts as an approach tunnel to the enzyme active site (Fig. 4 and Fig. S5B ). The hydrophobic channel begins at the site where the pantetheine sulfur atom is positioned, and terminates at the catalytic triad. All residues that form the hydrophobic channel are positioned on the capping domain helices and loops emanating from the central β-sheet of BioH.
Pimeloyl Methyl Ester Engagement in the BioH Active Site. The quality of the electron density maps allows for the unequivocal assignment of the carbonyl oxygen and the alcohol substituents at the pimeloyl ester C7 carbon atom. The carboxylate oxygen atom of the pimeloyl moiety bearing methyl ester is stabilized by a lone interaction with the imidazole side chain of H235 (2.9 Å). The other carboxylate oxygen is stabilized by interactions with the main-chain amide nitrogen atoms of L83 (2.8 Å) and W22 (2.8 Å). These two interactions constitute the "oxyanion hole" for stabilization of the tetrahedral hemiacetal intermediate generated during the protease/esterase reaction coordinate (15) (Fig. S3) .
The methyl carbon atom of the ester moiety points into a hydrophobic cage defined by the side chains of L24, W81, and F143. The hydrophobic cage for BioH likely causes the destabilization of the carboxylate negative charge for the product pimeloyl acid moiety, and thus contributes to product expulsion from the active site.
Effects of BioH Surface-Residue Substitutions on Esterase Activity in
Vitro. To test the enzymological and physiological relevance of the ionic interactions between BioH and ACP-α2 helix, we replaced these BioH residues (R138, R142, R155, and R159) with Ala and assembled a panel of single, double, triple, and quadruple mutants. We assayed the esterase activity of these BioH mutants in vitro using the cognate substrate Me-pimeloyl-ACP. The production of pimeloyl-ACP, which migrates more slowly than the substrate in a destabilizing urea-PAGE system, was monitored over 20 min (Fig. 5) . The wild-type enzyme and the single Arg-to-Ala substitution mutants had comparable activities, whereas the S82A mutant was completely inactive. With these BioH proteins, production of pimeloyl-ACP could be seen in as little as 30 s, and the reaction approached completion in ∼10 min. The activities of proteins containing two Ala substitutions were significantly reduced. The earliest sign of pimeloyl-ACP occurred at 2 min, and at 20 min the reactions remained incomplete. The activities of triple and quadruple Ala substitution mutants were greatly reduced, producing significantly less pimeloyl-ACP over the same time period. This result indicated that at least three Arg residues were needed to maintain a wild-type level of activity. Given the crystal structure, interpretation of these data in terms of the binding affinity between BioH and the ACP moiety of Me-pimeloyl-ACP seems straightforward and was confirmed by an electrophoretic mobility shift assay in which binding of the highly acidic Mepimeloyl-ACP to S82A BioH increased the mobility of BioH in nondenaturing gels (Fig. S6A ). S82A derivatives of the BioH R-to-A substitution mutants were found to have decreased affinities for the substrate that paralleled the activity assays. The double, triple, and quadruple Ala substitution mutants showed no detectable binding of Me-pimeloyl-ACP, whereas the protein retaining all four Arg residues had a K d of 3.1 μM. Finally, we assayed the ability of each of the mutant proteins to cleave 4-nitrophenyl acetate, a commonly used colorimetric esterase substrate. Each of the mutant proteins had essentially wild-type activity (2 mmol min
BioH) on this model substrate, indicating that active site function remained intact in the mutant proteins.
Effects of BioH Surface-Residue Substitutions on Biotin Synthesis. If the interactions seen in the crystal structure are of physiological relevance, decreased in vitro activities of the BioH proteins carrying Ala substitutions should result in decreased abilities to support biotin synthesis; this was tested using an E. coli strain in which both the bioH and pcnB genes had been deleted and that also carried pMS421, a lacI q plasmid. The various BioH proteins were expressed in plasmid pET28b, a vector often used to express proteins from its LacI-controlled phage T7 promoter. In this case, however, no phage T7 RNA polymerase was present, and bioH transcription was due to use of the T7 promoter by E. coli RNA polymerase (16) . The ΔpcnB mutation was included to decrease the copy number of the BioH plasmids by ∼10-fold (17). Replication of pMS421, which provided additional LacI to allow better control of BioH expression, is unaffected by the pcnB deletion. These manipulations were intended to allow detection of BioH mutants having significant, but incomplete, losses of esterase activity, which could be masked by high-level expression. Successful complementation absolutely required the catalytic S82 residue and the single R-to-A substitutions only modestly affected complementation activity (Fig. S7A) , although a brief lag was observed before exponential growth ensued. This growth lag was further extended in the double mutants and became much more prominent in the triple and quadruple mutants (Fig. S7A ). Because biotin is not consumed (as in most growth assays) but allows catalysis, the lag is explained by the time required to accumulate protein-bound biotin to the threshold level required for fatty acid synthesis. As growth proceeds, the levels of protein-bound biotin may fall below the threshold, but because E. coli can grow through several generations on accumulated lipids before growth cessation, the growth curve reaches stationary phase. In contrast, colony formation requires a much greater number of generations and thus provides a more stringent assay, as shown by the inability of the triple and quadruple BioH mutants to form colonies (Fig. S7B) . The effects of the alanine substitutions on growth were completely reversed by addition of biotin to the medium.
Discussion
Our 2.05-Å resolution cocrystal structure of BioH S82A in complex with its Me-pimeloyl-ACP substrate revealed salt-bridge interactions between the BioH capping domain and residues positioned close to the termini of ACP α2 helix (Fig. 3 and Fig. S5 ). This mode of ACP binding is also seen in the P450BioI-acyl ACP complexes (13), the castor desaturase-apo ACP complex (18) , and the EntE adenylation domain complex with the peptidyl carrier protein EntB (19) . Binding both ends of ACP helix 2 by BioH correctly positions the catalytically tethered serine residue (which lies at the amino terminus of the helix) of the carrier protein relative to BioH, to form a catalytically productive complex.
The cocrystal structure also provided an independent means to test the fate of the esterified pimelate moiety in the biotin biosynthetic pathway, namely through the disruption of interactions that mediate complex formation between BioH and ACP. Substitution of Ala for four Arg BioH residues, designed to disrupt interactions between BioH and the ACP moiety of Me-pimeloyl-ACP, inhibited ester hydrolysis in vitro and compromised the ability of plasmids encoding the altered enzymes to complement growth of the bioH deletion strain. When two or more BioH Arg residues were replaced, the enzymes lost activity in both the in vivo and in vitro assays and were completely inactivated with three or four replacements. Indeed, the effects of the various mutations on in vitro enzymatic activity and in vivo biotin synthetic ability were strikingly similar. Moreover, electrophoretic shift assays of binding of Me-pimeloyl-ACP to BioH S82A versions of the Arg substitution proteins showed progressive loss of binding as the number of substitutions increased (Fig. S6A) . Finally, all of the BioH mutant proteins retained a fully functional active site, as assayed by the ability to cleave a model esterase substrate. These data demonstrate that Me-pimeloyl-ACP is the physiological substrate of BioH, and that BioH functions as the gatekeeper in pimeloyl moiety synthesis by terminating elongation of the pimeloyl chain by the fatty acid synthetic pathway.
Though the enzyme-carrier protein interactions are conserved in BioH, BioI, and the castor desaturase, variability is found in the interactions of the substrate phosphopantetheine arm. In BioH, minimal interactions hold the phosphopantetheine arm within the active site, with one surface of the arm placed near hydrophobic residues and the other side of the arm being solvent-exposed (Fig. S5A) . In contrast, extensive water-mediated contacts were observed for the phosphopantetheine arm in the P450BioI-acyl ACP crystal structures (13) (in the castor desaturase-apo ACP crystal structure, the phosphopantetheine arm is truncated due to lack of electron density) (18) . Although the complete functional implications for the lack of direct or watermediated interactions between BioH and the phosphopantetheine arm of acyl-ACP are not clear, it provides the basis for postulating that efficient BioH hydrolysis of the Me-pimeloyl moiety requires tethering to an ACP molecule.
The structure reported argues that substrate specificity for ACPbound substrates has been engineered into BioH, such that only a pimeloyl methyl ester chain can be accepted. Although BioH does indeed accept glutaryl (C5), adipyl (C6), suberyl (C8), and azelayl (C9) methyl esters conjugated to ACP as substrates in addition to the physiological substrate pimeloyl (C7) methyl ester, the hydrolysis of these unnatural substrates was slower than that of the pimeloyl substrate (Fig. S6B ). An inspection of the BioH hydrophobic substrate channel, and the manner in which the phosphopantetheinylated fatty acid is directed into the enzyme active site, provides a rationale for these observations. The length of the hydrophobic channel cavity is organized to allow the pimeloyl moiety to efficiently reach the BioH catalytic triad, whereas the shorter glutaryl chain has difficulty in traversing this cavity, and longer chains would have steric clashes with the side chains of the BioH hydrophobic cavity, which would mitigate binding. The C6 (adipyl) species was a fair BioH substrate (Fig. S6B ) but is not germane to the pathway. The C5 substrate bound BioH (Fig. S6A) , but catalysis was slow (Fig. S6B) , and the C9 substrate bound BioH very poorly (Fig. S6A) . Hence, the dimensions of this hydrophobic cavity generate the specificity for BioH. This model for BioH specificity is supported by the structure-based primary sequence alignment of the BioH proteins of diverse bacteria (Fig. S8) , which shows a strict conservation of the hydrophobic residues implicated in generating the hydrophobic tunnel and for hydrophobic interactions with the pantetheine arm. The known ability of BioH to cleave short-chain (but not long-chain) 4-nitrophenol esters (8, 9) and the methyl ester of dimethylbutyryl-S-methyl mercaptopropionate (10) are consistent with the hydrophobicity and narrow aperture of the BioH channel, although accommodation of the bulky 4-nitrophenol group argues that the bottom of the channel can expand. Expansion would also explain the observed hydrolysis of the ethyl, propyl, and butyl esters of pimeloyl-ACP (4).
The complex of BioH with Me-pimeloyl-ACP is formed without significant structural changes in either the enzyme or the ACP moiety. Indeed, it seems that the only structural change required is partition of the acyl chain from the ACP hydrophobic core into the hydrophobic active site channel of BioH (vide infra). Following completion of the reaction, the newly formed carboxyl group would cause expulsion of the pimeloyl-pantetheine moiety from the BioH hydrophobic channel and return of the methylene chain to the ACP hydrophobic core with the carboxyl group protruding from the helical bundle and exposed to solvent.
We had previously postulated that BioC, the SAM-dependent methyl transferase, which methylates malonyl-ACP (or malonylCoA) to shunt a small portion of the flux of the fatty acid synthetic pathway toward biotin synthesis (Fig. 1) , may be an intrinsically poor catalyst (4). This lack of catalytic efficiency is also characteristic of the downstream enzymes of the pathway (20) (21) (22) (23) , and has been attributed to the traces of biotin required for cellular growth (24) . To verify this premise, we sought to determine the kinetic constants for the esterase reaction mediated by BioH and attempted several in vitro assays, all of which were unsuccessful. However, an estimate for the maximal catalytic rate for the enzyme can be obtained from the gel-shift assay (Fig.  5) . Wild-type BioH routinely hydrolyzed a 40,000-fold molar excess of Me-pimeloyl-ACP in less than 10 min. Assuming the substrate/enzyme molar ratio used in our in vitro experiments to be saturating for the enzyme, the k cat value for the ester hydrolysis by BioH can be minimally estimated to be 60 s −1 . This value is orders of magnitude greater than those reported for the downstream enzymes of the pathway (20) (21) (22) (23) . This mismatch of BioH catalytic activity with the other enzymes of the pathway and with the physiological need for only extremely modest amounts of biotin may indicate that the enzyme has not yet been fully integrated into E. coli biotin synthesis. Other indications are that the E. coli bioH gene is not located within bio operon or regulated by BirA, the repressor that controls expression of the other bio genes. Catalytically relevant amino acids identified by the crystal structure presented here are found to be highly conserved between BioH sequences that lie outside or within the bio operon under BirA control (Fig. S8) . Hence the mode of substrate engagement, and the model proposed for the generation of substrate specificity within the enzyme active site, seems to be independent of genetic positioning of the bioH gene.
Materials and Methods
Bacterial Media, Strains, Plasmids, and Oligonucleotides. See SI Materials and Methods.
Protein Purifications and Substrate Synthesis. See SI Materials and Methods for purification.
Crystallization, Phasing, and Structure Determination. The complex of Mepimeloyl-ACP with BioH S82A was crystallized by sparse matrix screening, followed by optimization of screening hits. See SI Materials and Methods for detailed procedures. The crystal structure of the complex of Me-pimeloyl-ACP with BioH S82A was determined by molecular replacement using apo wild-type BioH and E. coli ACP as the search models. See SI Materials and Methods for detailed procedures.
Assays. BioH proteins were assayed for their carboxylesterase activity on Mepimeloyl-ACP. Hydrolysis of the ester bond produces a slower-migrating pimeloyl-ACP that can be resolved by the conformationally sensitive electrophoretic mobility-shift assay described previously (4 Cloning, Protein Expression, and Purification. Preparation of plasmids encoding C-terminally hexahistidine-tagged derivatives of wild-type and the S82A BioH proteins encoded in vector pET28b+ (Novagen) have been described previously (1) . Single, double, triple, and quadruple BioH mutants designed to disrupt acyl carrier protein (ACP) binding were generated from the C-terminally hexahistidine-tagged wild-type protein by standard site-directed mutagenesis protocols (1) . The primers used were BioH R138A (5′-AGT GAT GAT TTT CAG GCT ACA GTG GAG CGG TTC-3′ and 5′-CTG AAA ATC ATC ACT GAG TTG CTG CTG AAA TCC-3′); BioH R142A (5′-CAG CGT ACA GTG GAG GCG TTC CTG GCG TTA CAA-3′ and 5′-CTC CAC TGT ACG CTG AAA ATC ATC ACT GAG TTG-3′); BioH R155A (5′-GGG ACT GAA ACG GCG GCC CAG GAT GCG CGG GCG-3′ and 5′-CGC CGT TTC AGT CCC CAT GGT TTG TAA CGC CAG-3′); BioH R159A (5′-GCG CGC CAG GAT GCG GCG GCG TTG AAG AAA ACC-3′ and 5′-CGC ATC CTG GCG CGC CGT TTC AGT CCC CAT GGT-3′); and BioH R159A/ R155A (5′-GGG ACT GAA ACG GCG GCC CAG GAT GCG GCG GCG-3′ and 5′-AGT GAT GAT TTT CAG GCT ACA GTG GAG GCG TTC-3′). All constructs were verified by DNA sequencing by ATGC Inc.
Wild-type and mutant BioH enzymes used in this study for crystallization and biochemical assays all carried a C-terminal fusion of hexahistidine tag (unless stated otherwise) and were purified identically. Clones were transformed into E. coli BL21(DE3) and cultures were grown in LB growth medium supplemented with 50 μg/mL kanamycin sulfate. Two liters of culture was grown at 37°C until an OD at 600 nm of 0.6, and protein production was induced by addition of 0.3 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The culture was then shifted to 18°C and further grown for 16 h. The cells were collected by centrifugation and resuspended in 20 mM Tris·HCl (pH 8.0), 500 mM NaCl, and 10% (wt/vol) glycerol buffer, and lysed by multiple passages through a C5 Avestin cell homogenizer. The lysate was centrifuged and the supernatant was applied to a 5-mL HisTrap (GE Biosciences) column equilibrated in the cell harvest buffer. The column was extensively washed with 20 mM Tris·HCl (pH 8.0), 1 M NaCl, and 30 mM imidazole buffer, and eluted by a linear gradient to 250 mM imidazole. Protein purity was determined by SDS/PAGE, and greater than 95% pure fractions were applied to a Superdex-75 size-exclusion chromatography column equilibrated with 20 mM Hepes (pH 7.5) and 100 mM KCl buffer. The peak fractions corresponding to the BioH monomer were pooled and concentrated. This procedure routinely yielded greater than 30 mg of highly pure protein per liter of culture. The protein concentrations were determined by Bradford assay (Bio-Rad).
Crystallization. The complex of pimeloyl-ACP methyl ester (Mepimeloyl-ACP) with BioH S82A was crystallized by sparse matrix screening, followed by optimization of screening hits. For crystallization, the BioH S82A mutant enzyme was concentrated to 0.6 mM and mixed in a 1:1.2 molar ratio with the Me-pimeloyl-ACP substrate. The complex was incubated at room temperature for 2 h. Crystallization screening was performed with various commercial crystallization screens by mixing 1 μL of protein complex with 1 μL of mother liquor in 48-well hanging-drop trays. Trays were incubated at 9°C and periodically monitored for crystal growth. Initial crystallization conditions were identified and refined to yield reproducible crystallization conditions: 28-32% (wt/vol) PEG1500, 5-10% (wt/vol) glycerol at 20°C. The crystals obtained were briefly soaked in mother liquor supplemented with 20% (wt/vol) glycerol and vitrified in liquid nitrogen for X-ray diffraction data collection at Life Sciences Collaborative Access Team, Sector 21, Argonne National Laboratory.
Phasing and Structure Determination. A fourfold redundant data set was collected from a single crystal of BioH S82A mutant enzyme in complex with Me-pimeloyl-ACP to a limiting resolution of 2.05 Å using a Mar 300 CCD detector at Life Sciences Collaborative Access Team 21ID-D, Argonne National Laboratory. Unit cell parameters were determined using iMOSLFM (2) and used as a reference for indexing using XDS (3). The structure of BioH S82A in complex with Me-pimeloyl-ACP substrate was solved by molecular replacement using an ensemble search model consisting of wildtype E. coli BioH crystal structure (PDB ID code 1M33) (4) and E. coli ACP derived from PDB ID code 3EJB (5). For each component of the ensemble search model, all water molecules and ligand atoms were removed. The solution obtained by the program Phaser (6) was imported into ARP/wARP (7), which allowed for a majority of residues to be automatically built. Cross-validation used 5% of the data in the calculation of the free R factor (8) . The remaining model, including the phosphopantetheine arm and pimeloyl-methyl ester, was built in manually when the free R factor dropped below 30% using Coot (9) . Solvent molecules were built by ARP/wARP solvent procedure and manually verified. The restraints definition for the phosphopantetheinylated pimeloyl-methyl ester was generated by Web-based PRODRG2 server (10) . Structure refinement was carried out by the Phenix refinement procedure (11) . The stereochemistry of the model was monitored throughout the course of refinement using MolProbity (12) . Relevant data collection and refinement statistics are provided in Table S1 .
In Vivo Complementation Assays. Strain STL243 (MG1655 ΔbioH:: FRT ΔpcnB::cat) was constructed by phage P1 transduction of strain SLL24 (1) with a lysate grown on MG1655 ΔpcnB::cat (a gift of Alexander Smith of the J.E.C. laboratory). Strain STL243 was transformed with plasmid pET28b carrying either the wildtype bioH gene or a mutant gene. The resulting strains were maintained in spectinomycin and kanamycin throughout the experiment. The strains were inoculated at 30°C overnight in 5 mL of M9 medium containing 0.8% (wt/vol) glycerol (M9 glycerol) and 1 nM biotin. A total of 1 mL of the cultures were collected, washed three times with M9 glycerol to remove biotin, and resuspended in 1 mL of M9 glycerol. Cell density was normalized to OD at 600 nm of 1. A total of 10 μL of the cells were then used to inoculate 1.5 mL of M9 glycerol. The growth analysis was performed on Bioscreen C (Growth Curves USA) using a proprietary 100-well microplate. Each well contained 250 μL of the cell suspension. Growth was monitored by OD at 600 nm at 37°C for 24 h with high agitation rate. The growth curve of each strain was plotted based on the mean OD from five replicates using OriginPro 8.6. SEs were all less than 2% of mean ODs.
Growth phenotypes were also tested by colony formation on solid medium (Fig. S6) .
Construction of Plasmids Encoding Biotinylation Peptide-Tagged BioF
and BioH, Protein Purification, and the Order-of-Addition Assay. In prior work, a plasmid (pSTL6) encoding a version of BioH with a Cterminal hexahistidine tag in pET28b was constructed (1). An analogous pET28b plasmid (pSTL3) encoding a C-terminal hexahistidine-tagged BioF was made in the same manner as the BioH plasmid using the following oligonucleotide primers: BioF forward (5′-GGC AGC ATC ATG AGC TGG CAG GAG AAA ATC-3′) and BioF reverse (5′-CAA TGG CTT GTC TCG AGA CCG TTG CCA TGC-3′). Both genes contained an XhoI site at the junction of the coding and tag sequences, which was used together to replace the C-terminal hexahistidine tags with a sequence encoding a peptide sequence (Pep-85) that becomes biotinylated by the E. coli BirA biotin protein ligase. Two oligonucleotides PEP-85 top (5′-TCG AGG GAG GAC TGA ACG ACA TCT TTG AAG CGC AAA AAA TCG AAT GGC ATT AAG CTT GC-3′) and PEP85 btm (5′-TCA GCA AGC TTA ATG CCA TTC GAT TTT TTG CGC TTC AAA GAT GTC GTT CAG TCC TCC C-3′) were annealed to give a double-stranded cassette having overhanging XhoI and BlpI ends. The BioH-encoding plasmid was digested with BlpI (located 50 bp downstream of the termination codon) and XhoI and ligated to the cassette to give plasmid pCY890, which encoded the BioH-Pep-85 fusion. DNA sequencing showed the construct had the expected sequence. Similar manipulations could not be done with the BioF plasmid because the bioF gene contains a BlpI site. Hence the BioH plasmid was digested with XhoI and ClaI (which cuts in the vector kanamycin resistance gene), and the smaller of the two resulting fragments containing the Pep-85 tag was ligated to the larger fragment of pSTL3 cut with the same enzymes to give the BioF-Pep-85 fusion protein expression plasmid pCY889. Plasmids pCY889 and pCY890 encoded active proteins, as shown by their abilities to allow growth of ΔbioF and ΔbioH strains, respectively, in the absence of biotin.
Plasmids pCY889 and pCY890 were used to transform strain Tuner (DE3) carrying additional copies of birA (the E. coli gene encoding biotin protein ligase) encoded on a second plasmid, pCY216 (13) . The resulting strains were maintained in chloramphenicol and kanamycin throughout the experiment. For expression of BioF and BioH, the strains were inoculated in 5 mL of LB at 30°C overnight, and subcultured at 1:100 ratio in 250 mL of 2XYT medium. The cells were grown at 37°C until OD at 600 nm reached 0.6. Arabinose was added to 0.02% (wt/vol) to induce expression of BirA for 30 min, and then IPTG was added to 0.1 mM to induce expression of BioF or BioH for 3 h. The cells were collected by centrifugation, resuspended in lysis buffer [100 mM sodium phosphate (pH 6.5), 150 mM NaCl, 10% (wt/vol) glycerol, and 1 mM Tris(2-carboxyethyl)phosphine (TCEP)], and lysed by French press treatment at 17,500 psi. Ammonium sulfate was added slowly to the soluble cell extract to 55% (wt/vol) saturation under constant stirring on ice. After 30 min of stirring, protein pellet was collected by centrifugation at 20,000 × g. The pellet was washed three times, each with 20 mL of lysis buffer containing 55% (wt/vol) ammonium sulfate. The pellet was then dissolved in lysis buffer and biotintagged BioF or BioH was purified by monomeric avidin agarose (Pierce). The agarose was washed with 30 column volumes of lysis buffer, and the biotin-tagged proteins were eluted with lysis buffer containing 4 mM biotin. The proteins were dialyzed extensively in lysis buffer to remove biotin and concentrated using Amicon Ultra centrifugal filters (Millipore). Protein concentrations were determined by Bradford assay (Bio-Rad) using bovine serum globulin (Pierce) as standard.
The BioH-BioF order-of-addition assay allows in vitro conversion of Me-pimeloyl-ACP to dethiobiotin (DTB) using pure BioH, BioF, BioA, and BioD enzymes. The assay was divided into two reactions. In the first reaction, Me-pimeloyl-ACP was incubated with BioH, BioF, or both plus the required substrates to give pimeloyl-ACP, 7-keto-8-aminopelargonic acid (KAPA) methyl ester, or KAPA as potential products. In the second reaction, these products were converted to DTB by adding the other three enzymes. The first reaction (50 μL) contained assay premix [50 mM 3-(N-morpholino)propanesulfonic acid (pH 7.5), 100 mM NaCl, 10 mM MgCl 2 , 10% (wt/vol) glycerol, 2.5 mM DTT, 10 mM L-Ala, and 100 μM pyridoxal-5′-phosphate], 10 μM Me-pimeloyl-ACP, and 1 nM of either biotin-tagged BioH or biotin-tagged BioF. The reaction was incubated at 37°C for 1 h. The biotin-tagged proteins were removed by incubation with 25 μL of streptavidin agarose (Novagen; binding capacity of 2 nmol of biotin per 25 μL) on ice for 30 min. The agarose bead was separated from the supernatant using a spin filter. The second reaction (100 μL) contained 50 μL of the supernatant, assay premix, 2 mM potassium bicarbonate, 2.5 mM ATP, 2.5 mM SAM, 10 nM BioA, 10 nM BioD, and 1 nM of either BioH or BioF. The reaction was incubated at 37°C for 1 h and quenched by boiling for 10 min. A total of 20 μL of each reaction was spotted on DTB bioassay plates containing strain ER90 as described previously (1).
Synthesis of Me-Pimeloyl-ACP. Enzymatic preparation of Mepimeloyl-ACP was adapted from the methods of Lin et al. (1) . Briefly, the acylation reaction contained 50 mM Tris·HCl (pH 8.5), 10 mM MgCl 2 , 0.5 mM TCEP, 5 mM ATP, 5 mM Me pimelate, 1 mM ACP, and 50 μM AasS. The reactions were incubated at 37°C for 1.5 h. Me-pimeloyl-ACP was purified by ionexchange chromatography using Vivapure D spin columns (GE Healthcare Life Sciences). The reaction mixture was diluted fivefold in binding buffer [25 mM 4-morpholineethanesulfonic acid (pH 6), 10% (wt/vol) (vol/vol) glycerol, and 1 mM TCEP] containing 100 mM LiCl, and loaded into the column. The column was washed with binding buffer containing 250 mM LiCl, and the ACP was eluted in binding buffer containing 500 mM LiCl. Me-pimeloyl-ACP was desalted by dialysis in binding buffer, and concentrated using Amicon Ultra centrifugal filter (Millipore). The ACP product was analyzed in a conformationally sensitive electrophoretic mobility shift assay in 20% polyacrylamide gels containing 2 M urea at 130 V for 3.5 h. ACP was stained with Coomassie Blue R250. Other acyl-ACPs were prepared by the same method.
Me-Pimeloyl-ACP Hydrolysis Assay. The reactions contained 100 mM sodium phosphate (pH 7), 200 μM Me-pimeloyl-ACP, and 5 nM BioH. The hydrolysis reaction was monitored at seven time-points over a course of 20 min using the following protocol. A premix of buffer and ACP substrate, without BioH, was incubated at 37°C for 1 min. The hydrolysis reaction was initiated by adding BioH. At each time point, the reaction was sampled, immediately quenched by addition of an equal volume of 10 M urea, and stored on dry ice until analysis. The reaction samples were mixed with loading dye [100 mM 2-(N-morpholino)ethanesulfonic acid (pH 6) and 70% (wt/vol) glycerol] at 2:1 ratio before loading into the gel (1).
4-Nitrophenyl Acetate Hydrolysis Assay. The hydrolysis of 4-nitrophenyl acetate by BioH produced 4-nitrophenol, which was monitored by OD at 405 nm. The 500-μL reaction contained 100 mM Mes (pH 6.5), 10 mM 4-nitrophenyl acetate, 10% (vol/vol) dimethyl sulfoxide, and 10 nM BioH. Kinetic analysis was performed at room temperature in a Beckman Coulter DU 800 spectrophotometer. The reaction was equilibrated without BioH for 1 min and 20 s, initiated by adding BioH, and monitored continuously for a total of 7 min. Mean reaction rates and SEs were determined from three replicate experiments.
Electrophoretic Gel-Shift Assay of BioH-ACP Complex Formation.
BioH S82A was incubated with various molar ratios of Mepimeloyl-ACP to form a complex, which was detected by EMSA; briefly, a 10-μL reaction consisting of 10 μM BioH and 10 μM, 20 μM, 50 μM, or 100 μM of a methyl dicarboxylate-ACP in 50 mM Hepes (pH 7.5) containing 150 mM KCl. The reaction was incubated at 37°C for 10 min, mixed with 5 μL of loading dye (1.5× Tris-borate-EDTA buffer in 60% (wt/vol) glycerol), and loaded into a 15-well 6% DNA Retardation Gel (Invitrogen). BioH monomer and the complex were separated by electrophoresis in Tris-glycine buffer (10 mM Tris, 100 mM glycine) at 70 V for 100 min at room temperature. The proteins were visualized by staining with Coomassie Blue R250. Me-glutaryl-ACP and Meazelayl-ACP were assayed in parallel to determine the effect of acyl chain length on BioH binding. The S82A versions of the BioH Arg mutants were assayed by the same method.
Bacterial Strains. Escherichia coli strains ER90 (14, 15) , YFJ239 (16), DK574/pJT93 (17) , and STL24 (1) were described previously. BL21(DE3) was from Invitrogen and Tuner (DE3) was from Novagen. Fig. S1 . In vitro order-of-addition assay. (A) Me-pimeloyl-ACP was the substrate for in vitro synthesis of KAPA by two putative routes, producing either pimeloyl-ACP or KAPA methyl ester as intermediates. KAPA would eventually be converted by the BioA and BioD reactions to DTB for bioassay. BioH and BioF were biotin-tagged to allow their quantitative removal by binding to streptavidin agarose before addition of the second enzyme. (B) The production of DTB, via the synthesis of KAPA, was visualized on the bioassay plate as described in Materials and Methods. AMTOB, S-adenosyl-2-oxo-4-methylthiobutyric acid. Because of the small size and low pI of ACP, the acyl-ACPs migrated through these high-porosity gels and were not observed. Note also that the highly acidic ACP stains much more poorly with Coomassie Blue than BioH, and hence the staining of the shifted species seems almost entirely to reflect BioH staining. (B) Wild-type BioH-catalyzed hydrolysis of ACP thioesters of the methyl esters of glutarate, adipate, pimelate, suberate, and azelate. The product is the slower-migrating ω-carboxyl-ACP, which can be resolved from the substrates in a destabilizing urea-PAGE system as described in SI Materials and Methods. Fig. S7 . Alanine substitutions for residues R138, R142, R155, and R159 reduced BioH activity in vivo as assayed by growth curves (A) and colony formation (B). The effect of Ala substitutions on BioH activity was investigated by assaying complementation of a ΔbioH strain. The chromosomal bioH gene of the host strain was deleted, and a plasmid encoding BioH was required to complete biotin biosynthesis and sustain cell growth. (A) The strain carrying the empty vector or that expressing the S82A mutant protein failed to grow. Exponential growth of cultures expressing the single Ala substitution mutants was slightly delayed. These cultures required more time to accumulate sufficient biotin to support fatty acid synthesis. The lag became more apparent in the double mutants and increased to nearly 10 h in the triple and quadruple mutants. coli BioH with homologs demonstrate conservation of catalytically relevant residues. Residues comprising of the esterase catalytic triad are marked by a triangle (▲) under the residues; residues implicated for ACP binding are marked by a diamond (♦) under the residues, and residues which form the hydrophobic channel for directing the pimeloyl methyl ester toward the catalytic site, and for coordinating the methyl ester are marked by a circle (•) under the residues. The four helices of the BioH capping domain are shown by a cartoon above the residues. Residue numbering is that of E. coli BioH. Primary sequence alignment was generated by ClustalW (19) and imported into ALINE (20) for figure generation. Ec_BioH, BioH sequence from E. coli; Mf_BioH, BioH sequence from Methylobacillus flagellates KT; Ne_BioH, BioH sequence from Nitrosomonas europaea; Pa_BioH, BioH sequence from Pseudomonas aeruginosa; Sm_BioH, BioH sequence from Serratia marcescens. Note that Ec_BioH and Sm_BioH lie outside their respective bio operons, whereas Ne_BioH, Mf_BioH, and Pa_BioH lie within their respective bio operons. 
